Financial statements Bader-Drog
Balance sheet data of BADER-DROG
Year
|
2021
|
2022
|
2023
|
2024
|
---|---|---|---|---|
Total assets | 60 720,09 | 76 158,17 | 144 894,18 | 161 364,57 |
A. Fixed assets | 1 000,00 | 1 000,00 | 1 000,00 | 1 000,00 |
B. Current assets | 59 720,09 | 75 158,17 | 143 894,18 | 160 364,57 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 60 720,09 | 76 158,17 | 144 894,18 | 161 364,57 |
A. Equity | 35 871,82 | -16 693,97 | 73 901,76 | 86 383,47 |
B. Liabilities and provisions for liabilities | 24 848,27 | 92 852,14 | 70 992,42 | 74 981,10 |
I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 |
II. Short-term liabilities | 24 848,27 | 92 852,14 | 70 992,42 | 74 981,10 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.